Medipyxis
blog8 min read

Wound Care Market Analysis: Identifying Underserved Areas

How to identify underserved wound care markets using demand indicators, competitive analysis, demographic data, payer landscape assessment, and market entry strategy frameworks.

D

Damon Ebanks

Medipyxis

Wound Care Market Analysis: Identifying Underserved Areas

Wound Care Market Analysis: Finding Where Demand Exceeds Supply

Wound care market analysis is the foundation of every expansion decision. Whether you're launching a new practice, adding territory, or evaluating an acquisition target, the core question is the same: where does wound care demand exceed the available supply of wound care providers?

Most practice owners answer this question with intuition. They know a market "feels" underserved because they hear from referral sources in adjacent areas, or they see patients traveling long distances for treatment. Intuition is a starting point, not a strategy. Systematic market analysis replaces guesswork with data and converts market selection from a gamble into a calculated decision.

This guide walks through the analytical framework for identifying underserved wound care markets: quantifying demand, mapping the competitive landscape, assessing the payer environment, and building a market entry strategy grounded in evidence.


Demand Indicators for Wound Care Services

Wound care demand is a function of population health characteristics, not just population size. A city of 200,000 with a young, healthy population generates less wound care demand than a rural county of 50,000 with high rates of diabetes, peripheral vascular disease, and an aging demographic.

Primary Demand Drivers

Diabetes prevalence is the single strongest predictor of chronic wound demand. Diabetic foot ulcers affect approximately 15% of diabetic patients during their lifetime, and the management of these ulcers drives a disproportionate share of wound care visit volume. Counties with diabetes rates above the national average (currently around 11.6% of the adult population) represent higher-demand markets.

Medicare population density matters because Medicare patients generate the majority of wound care reimbursement. Areas with higher concentrations of Medicare beneficiaries -- retirement communities, rural areas with aging-in-place populations -- have greater wound care demand per capita.

SNF and assisted living facility concentration creates clustered demand. Each facility represents a potential referral source with multiple wound care patients. Markets with 10+ SNFs within a 30-mile radius have enough facility density to support a full-time wound care clinician focused solely on facility-based care.

Home health agency presence indicates existing infrastructure for home-based healthcare delivery. Markets with multiple home health agencies but no dedicated wound care providers represent the highest-opportunity gap: the referral infrastructure exists, but the specialized wound care service does not.

Where to Find the Data

  • CDC Diabetes Atlas: County-level diabetes prevalence data updated annually
  • CMS Geographic Variation Public Use File: Medicare utilization by hospital referral region
  • NPPES NPI Registry: Count wound care-related NPIs by ZIP code to map existing provider supply
  • State licensing databases: Identify active wound care clinicians by geography
  • CMS Provider of Services file: SNF locations and bed counts by county

For the broader wound care market size context, see Wound Care Market Size and Growth 2026.


Competitive Landscape Assessment

Identifying demand isn't enough. You need to know who already serves that demand and where the gaps are.

Mapping Existing Providers

Search the NPI Registry for wound care-relevant taxonomy codes in your target market. Key taxonomies include:

  • 261QP0905X (Wound Care Center)
  • 207RP1001X (Phlebology -- vein/wound)
  • Podiatry (213E00000X) -- significant overlap with diabetic wound care
  • Home Health (251E00000X) -- competes for some wound care referrals

Count the providers, map their locations, and estimate their capacity. A market with two wound care centers serving a population that should generate demand for five has a quantifiable supply gap.

Assessing Competitive Quality

Provider count alone doesn't tell you whether the market is underserved. A market with three wound care providers who have poor outcomes, long wait times, or limited hours may be functionally underserved despite having adequate provider count.

Talk to referral sources. Call SNF directors of nursing, home health agency clinical managers, and primary care offices in the target market. Ask about current wound care provider availability, response times, and satisfaction. These conversations reveal the lived experience of the market better than any database search.

Identifying Service Gaps

Look for gaps in service type, not just provider count:

  • Home-based wound care. Many markets have hospital-based wound care centers but no mobile providers who see patients at home.
  • Facility-based wound care. Some markets have home health wound care but no providers who serve SNFs consistently.
  • Complex wound specialization. Markets may have general wound care but lack providers experienced with skin substitutes, negative pressure wound therapy, or hyperbaric referral coordination.
  • Weekend and evening availability. Markets with wound care providers who only operate Monday-Friday 8-5 have unmet demand outside those hours.

Payer Landscape Assessment

The same wound care visit generates different revenue depending on the payer mix in your target market. A market with strong demand but unfavorable payer dynamics may not be economically viable.

Key Payer Variables

Traditional Medicare vs. Medicare Advantage mix. Traditional Medicare reimburses wound care at predictable rates with standardized coverage rules. Medicare Advantage plans may require prior authorization, have different coverage policies, restrict network participation, and negotiate lower reimbursement rates. Markets where MA penetration exceeds 50% will have different economics than traditional Medicare-dominant markets.

Medicaid coverage. Medicaid reimbursement for wound care is significantly lower than Medicare in most states. Markets where Medicaid makes up more than 25% of the payer mix need higher visit volume to achieve the same revenue as Medicare-dominant markets.

Commercial insurance penetration. For wound care practices treating working-age patients (diabetic wounds, traumatic wounds, post-surgical complications), commercial insurance pays higher rates but typically represents a smaller percentage of total wound care volume.

Obtain the CMS Medicare Advantage enrollment data for your target counties. Cross-reference with state Medicaid enrollment data. This gives you a realistic picture of what your revenue per visit will look like before you commit to the market.


Market Entry Strategy

Once you've identified a market with strong demand, manageable competition, and viable payer dynamics, the entry strategy determines whether you capture the opportunity or waste your first-mover advantage.

Phase 1: Referral Source Development (Months 1-3)

Before you see your first patient, develop relationships with 5-10 referral sources. Visit SNFs, home health agencies, and primary care practices in person. Present your clinical capabilities, response time commitments, and communication standards. Ask what frustrates them about their current wound care options. Build your service model around solving their specific pain points.

Phase 2: Credentialing and Enrollment (Concurrent with Phase 1)

Start Medicare enrollment and commercial payer credentialing immediately. The 90-120 day timeline means you need to initiate this process before you've validated the market through referral conversations. This is a calculated risk -- you're investing administrative time before you're certain about market entry.

Phase 3: Initial Patient Volume (Months 3-6)

Begin seeing patients as soon as credentialing clears. Target 3-5 patients per day initially, concentrating visits in geographic clusters to maximize efficiency. Prioritize reliability over volume -- showing up on time, providing thorough documentation to referral sources, and communicating treatment progress consistently.

Phase 4: Scaling (Months 6-12)

Add clinician capacity as volume warrants. A market is validated when referral sources are sending patients faster than your current capacity can absorb them. That's the signal to hire, not a projected growth curve on a spreadsheet.

For how this analysis connects to territory planning for existing practices, see Wound Care Territory Expansion Strategy.


Tools and Data Sources Summary

Building a market analysis requires pulling data from multiple sources. No single database gives you the complete picture.

Data PointSourceUpdate Frequency
Diabetes prevalence by countyCDC Diabetes AtlasAnnual
Medicare beneficiary densityCMS Geographic Variation FileAnnual
SNF locations and bed countsCMS Provider of ServicesQuarterly
Active wound care providersNPPES NPI RegistryMonthly
Medicare Advantage penetrationCMS MA Enrollment DataMonthly
Home health agency coverageCMS Home Health CompareQuarterly
Population demographicsCensus Bureau ACSAnnual

Combine quantitative data with qualitative intelligence from referral source conversations. The data tells you where demand exists. The conversations tell you whether that demand is being adequately served.


Key Takeaways

  • Diabetes prevalence, Medicare population density, and SNF concentration are the three strongest quantitative predictors of wound care demand in a geographic market
  • Competitive analysis should go beyond provider count to assess service gaps -- home-based vs. facility-based care, complex wound specialization, and availability outside standard business hours
  • Payer mix determines revenue per visit, and markets with high Medicare Advantage penetration (>50%) or high Medicaid share (>25%) require higher volume to achieve the same economics as traditional Medicare-dominant markets
  • Start referral source development and Medicare credentialing simultaneously, since the 90-120 day enrollment timeline is the binding constraint on market entry speed
  • Quantitative data from CDC, CMS, and NPI databases provides the foundation, but qualitative intelligence from referral source conversations reveals whether existing demand is being adequately served

Want to learn more about Medipyxis?

Explore how mobile wound care practices use Medipyxis to reduce denials and capture more referrals.